rhabdomyosarcoma
Showing 26 - 50 of 363
Sarcoma Trial in New York (biological, drug, procedure, radiation)
Active, not recruiting
- Sarcoma
- filgrastim
- +10 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Nov 5, 2021
International PPB/DICER1 Registry
Recruiting
- Pleuropulmonary Blastoma
- +14 more
-
Minneapolis, MinnesotaChildren's Minnesota
Aug 16, 2022
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
Completed
- Recurrent Childhood Acute Myeloid Leukemia
- +13 more
-
Miami, FloridaNicklaus Children's Hospital
Jan 18, 2023
Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma Trial in Milwaukee (Allogeneic HCT, Donor NK Cell Infusion)
Active, not recruiting
- Ewing Sarcoma
- +4 more
- Allogeneic HCT
- Donor NK Cell Infusion
-
Milwaukee, Wisconsin
- +1 more
Apr 5, 2022
Rhabdomyosarcoma Trial in Houston (TAA-Specific CTLs)
Completed
- Rhabdomyosarcoma
- TAA-Specific CTLs
-
Houston, Texas
- +1 more
Apr 8, 2022
Ewing Sarcoma, Rhabdomyosarcoma Trial in Boston, Memphis (Olaparib, Temozolomide, Irinotecan)
Recruiting
- Ewing Sarcoma
- Rhabdomyosarcoma
- Olaparib
- +2 more
-
Boston, Massachusetts
- +4 more
Oct 27, 2021
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)
Recruiting
- Osteosarcoma
- +9 more
- Cryoablation Therapy
- +2 more
-
Washington, District of ColumbiaChildren's National Hospital
Mar 21, 2022
Lung Cancer, Ovarian Cancer, Uterine Cancer Trial in United States (OmniSeq Test)
Recruiting
- Lung Cancer
- +12 more
- OmniSeq Test
-
Fort Payne, Alabama
- +7 more
Jan 16, 2023
Recurrent Alveolar Rhabdomyosarcoma, Recurrent Ewing Sarcoma, Recurrent Lymphoma Trial in United States (Elimusertib)
Recruiting
- Recurrent Alveolar Rhabdomyosarcoma
- +7 more
-
Birmingham, Alabama
- +28 more
Jan 26, 2023
Solid Tumors, Soft Tissue Sarcoma, Ewing Sarcoma Trial (Magnetic Resonance-Guided High Intensity Focused Ultrasound,
Not yet recruiting
- Solid Tumors
- +8 more
- Magnetic Resonance-Guided High Intensity Focused Ultrasound
- Lyso-thermosensitive Liposomal Doxorubicin
- (no location specified)
Mar 10, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))
Terminated
- Ewing Sarcoma
- +10 more
- Stereotactic Body Radiotherapy (SBRT)
-
Boston, Massachusetts
- +2 more
Apr 5, 2021
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Pediatric Cancer, Solid Tumors, Rhabdomyosarcoma Trial in Washington (Magnetic resonance high intensity focused ultrasound,
Recruiting
- Pediatric Cancer
- +9 more
- Magnetic resonance high intensity focused ultrasound
- Lyso-thermosensitive liposomal doxorubicin
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 10, 2021
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)
Recruiting
- Pediatric Solid Tumor
- +7 more
- CLR 131
-
Palo Alto, California
- +6 more
Nov 30, 2021
Rhabdomyosarcoma, Non-Rhabdo. Soft Tissue Sarcoma Trial in Toronto (18F-FAZA (F18-Fluoroazomycin Arabinoside), Blood Oxygen
Enrolling by invitation
- Rhabdomyosarcoma
- Non-Rhabdo. Soft Tissue Sarcoma
- 18F-FAZA (F18-Fluoroazomycin Arabinoside)
- +3 more
-
Toronto, Ontario, CanadaThe Hospital for Sick Children
Nov 24, 2021
Advanced MR Imaging in Sarcoma Patients
Completed
- Sarcoma
-
Rochester, MinnesotaMayo Clinic
Feb 11, 2022
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Hodgkin Lymphoma Trial in Madison (TCRaß+/CD19+ depleted Haploidentical
Recruiting
- Acute Myeloid Leukemia
- +10 more
- TCRαβ+/CD19+ depleted Haploidentical HSCT
- Zoledronate
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Mar 1, 2022
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
Relapsed Pediatric Solid Tumors, Refractory Pediatric Solid Tumors, Rhabdomyosarcoma Trial in Washington, Cincinnati (Magnetic
Active, not recruiting
- Relapsed Pediatric Solid Tumors
- +9 more
- Magnetic Resonance High Intensity Focused Ultrasound
-
Washington, District of Columbia
- +1 more
Jan 21, 2022
Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosarcoma Trial in United States (MM-398 (Irinotecan Sucrosofate
Recruiting
- Recurrent or Refractory Solid Tumors
- +4 more
- MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide
-
Cincinnati, Ohio
- +5 more
Mar 17, 2022